Analogy of cardiac and renal complications in essential hypertension and aged SHR or L-NAME/SHR

Medicinal Chemistry

Volumn 3, Issue 1, 2007, Pages 61-65

  Zhou, Xiaoyan ^a   Frohlich, Edward D ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Cardiac failure; End stage renal disease; Experimental model; Hypertension

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST; CANDESARTAN; CAPTOPRIL; CILNIDIPINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPLERENONE; FELODIPINE; LISINOPRIL; LOSARTAN; MIBEFRADIL; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; QUINAPRIL; RAMIPRIL; THIAZIDE DIURETIC AGENT;

ARTERY DILATATION; ARTICLE; CARDIOVASCULAR FUNCTION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CORONARY ARTERY BLOOD FLOW; CORONARY VASCULAR RESISTANCE; DISEASE MODEL; ESSENTIAL HYPERTENSION; GLOMERULOSCLEROSIS; HEART FAILURE; HEART MUSCLE FIBROSIS; HEART PROTECTION; HUMAN; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY ISCHEMIA; MONOTHERAPY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEINURIA; RAT; RENAL PROTECTION; RENOVASCULAR HYPERTENSION; SPONTANEOUSLY HYPERTENSIVE RAT; SURVIVAL RATE; TREATMENT OUTCOME;

AGING; ANIMALS; ANTIHYPERTENSIVE AGENTS; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; HEART DISEASES; HYPERTENSION; KIDNEY DISEASES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, INBRED SHR;

EID: 33846070720     PISSN: 15734064     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340607779317634     Document Type: Article

References (68)

1. Chobanian, A.V.; Bakris, G.L.; Black, H.R.; Cushman, W.C.; Green, L.A.; Izzo, J.L. Jr; Jones, D.W.; Materson, B.J.; Oparil, S.; Wright, J.T. Jr; Roccella, E.J. JAMA, 2003, 289, 2560.
2. Whitworth, J.A. World Health Organization, International Society of Hypertension Writing Group. J. Hypertens., 2003, 21, 1983.
3. Collins, R.; Pete, R.; MacMahon, S.; Hebert, P.; Fiebach, N.H.; Eberlein, K.A.; Godwin, J.; Qizilbash, N.; Taylor, J.O.; Hennekens, C.H. Lancet, 1990, 335, 827.
4. Frohlich, E.D. Med. Clin. North Am., 2004, 88, 209.
5. Frohlich, E.D. Curr. Opin. Cardiol., 2005, 20, 258.
6. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. U. S. Renal Data System, 2004.
7. Frohlich, E.D. Hypertension, 1999, 34, 782.
8. Frohlich, E.D.; Apstein, C.; Chobanian, A.V.; Devereux, R.B.; Dustan, H.P.; Dzau, V.; Fauad-Tarazi, F.; Horan, M.J.; Marcus, M.; Massie, B.M.; Pfeffer, A.; Re, R.N.; Roccella, E.J.; Savage, D.; Shub, C. N. Engl. J. Med., 1992, 327, 998.
9. Treasure, C.B; Klein, J.L.; Vita, J.A.; Manoukian, S.V.; Renwick, G.H.; Selwyn, A.P.; Ganz, P.; Alexander, R.W. Circulation, 1993, 87,86.
10. Laviades, C.; Varo, N.; Fernandez, J.; Mayor, G.; Gil, M.J.; Monreal, I.; Diez, J. Circulation, 1998, 98, 535.
11. Querejeta, R.; Lopez, B.; Gonzalez, A.; Sanchez, E.; Larman, M.; Martinez Ubago, J.L.; Diez, J. Circulation, 2004, 110, 1263.
12. Diez, J.; Gonzalez, A.; Lopez, B.; Querejeta, R. Nat. Clin. Pract. Cardiovasc. Med., 2005, 2, 209.
13. Gonzalez, A.; Forturo, M.A.; Querejeta, R.; Ravassa, S.; Lopez, B.;Lopez, N.; Diez, J. Cardiovasc. Res., 2003, 59, 549.
14. Fortano, M.A.; Gonzalez, A.; Ravassa, S.; Lopez, B.; Diez, J. Am. J. Physiol. Heart Circ. Physiol., 2003, 284, H1495.
15. Neuringer, JR.; Brenner, B.M. Am. J. Kidney Dis., 1993, 22, 98.
16. Ritz, E.; Fliser, D.; Siebels, M. Am. J. Hypertens., 1993, 6, 241S.
17. Ono, H.; Ono, Y. Med. Clin. North Am., 1997, 81, 1273.
18. Ono, H.; Ono, Y.; Frohlich, E.D. Hypertension, 1995, 26, 249.
19. Frohlich, E.D. Hypertension, 1997, 29, 188.
20. Zhou, X.; Frohlich, E.D. Am. J. Nephrol., 2005, 25, 138.
21. Trippodo, N.C.; Frohlich, E.D. Circ. Res., 1981, 48, 309.
22. Susic, D.; Nunez, E.; Hosoya, K.; Frohlich, E.D. J. Hypertens., 1998, 16, 231.
23. Boluyt, M.O.; Bing, O.H.; Lakatta, E.G. Eur Heart J., 1995, 16, 19.
24. Li, Z.; Bing, O.H.; Long, X.; Robinson, K.G.; Lakatta, E.G. Am. J. Physiol., 1997, 272, H2313.
25. Komatsu, K.; Frohlich, E.D.; Ono, H.; Ono, Y.; Numabe, A.; Willis, G.W. Hypertension, 1995, 25, 207.
26. Zhou, X.J.; Vaziri, N.D.; Zhang, J.; Wang, H.W.; Wang, X.Q. Kidney Int., 2002, 62, 914.
27. Furchgott, R.F. JAMA, 1996, 276, 1186.
28. Ignarro, L.J.; Buga, G.M.; Wei, L.H.; Bauer, P.M.; Wu, G.; del Soldato, P. Proc. Natl. Acad. Sci. USA, 2001, 98, 4202.
29. Brand-Schieber, E.; Pucci, M.; Nasjletti, A. Am. J. Physiol., 1996, 270, R1203.
30. Zanchi, A.; Schaad, N.C.; Osterheld, M.C.; Grouzmann, E.; Nussberger, J.; Brunner, H.R.; Waeber, B. Am. J. Physiol., 1995, 268, H2267.
31. Devlin, A.M.; Brosnan, M.J.; Graham, D.; Morton, J.J.; McPhaden, A.R.; McIntyre, M.; Hamilton, C.A.; Reid, J.L.; Dominiczak, A.F. Am. J. Physiol., 1998, 274, H52.
32. Graciano, M.L.; Cavaglieri Rde, C.; Delle, H.; Dominguez, W.V.; Casarini, D.E.; Malheiros, D.M.; Noronha, I.L. J. Am. Soc. Nephrol., 2004, 15, 1805.
33. Ingelfinger, J.R.; Dzau, V.J. J. Am. Soc. Nephrol., 1991, 2, S9.
34. Hirsch, A.T.; Pinto, Y.M.; Schunkert, H.; Dzau, V.J. Am. J. Cardial., 1990, 66,22D.
35. Schlaich, M.P.; Kaye, D.M.; Lambert, E.; Sommerville, M.; Socratous, F.; Esler, M.D. Circulation, 2003,108,560.
36. Zbou, M.S.; Adam, A.G.; Jainnes, E.A.; Raij, L. Hypertension, 2003,42,945.
37. Navar, L.G. Kidney Int., 2004, 65,1522.
38. Ravassa, S.; Fortune, M.A.; Gonzalez, A.; Lopez, B.; Zalba, G.; Fortuno, A.; Diez, J. Hypertension, 2000,36,1065.
39. Gonzalez, A.; Lopez, B.; Ravassa, S.; Querejeta, R.; Larman, M.; Diez, J.; Fortano, M.A. Hypertension, 2002, 39, 75.
40. Ono, Y.; Ono, H.; Matsuoka, H.; Fujimori, T.; Frohlich, E.D. Hypertension, 1999, 34, 609.
41. Ono, H.; Ono, Y.; Takanohashi, A.; Matsuoka, H.; Frohlich, E.D. Hypertension, 2001, 38,1300.
42. Susic, D.; Varagic, J.; Frohlich, E.D. J Hypertens., 1999,17,1209.
43. Susic, D.; Francischetti, A.; Frohlich, E.D. Hypertension, 1999, 33, 451.
44. Ono, H., Ono, Y.; Frohlich, E.D. J Hypertens., 1999,17,121.
45. Francischetti, A.; Ono, H.; Frohlich, E.D. Hypertension, 1998, 31, 795.
46. Nakamura, Y.; Ono, H.; Frohlich, E.D. Hypertension, 1999, 34, 273.
47. Zhou, X.; Ono, H.; Ono, Y.; Frohlich, E.D. J Hypertens., 2002, 20, 993.
48. Ono, H.; Ono, Y.; Frohlich, E.D. Hypertension, 1996,27,176.
49. Zhou, X.; Ono, H.; Ono, Y.; Frohlich, E.D. Am. J. Nephrol., 2004, 24,242.
50. Nakamura, Y., Ono, H.; Zhou, X.; Frohlich, E.D. Hypertension 2001, 37,1092.
51. Zhou, X.; Matavelli, L.C.; Ono, H.; Frohlich, E.D. Am. J Physiol. Renal. Physiol., 2005,289, F871.
52. Rocha, R., Stier, C.T. Jr.; Kifor, L; Ochoa-Maya, M.R.; Rennke, H.G.; Williams, G.H.; Adler, G.K. Endocrinology, 2000, 141, 3871.
53. Pitt, B.; Reichek, N.; Willenbrock, R.; Zannad, F.; Phillips, R.A.; Roniker, B.; Kleiman, J.; Krause, S.; Bums, D.; Williams, G.H. Circulation, 2003, 108, 1831.
54. Blasi, E.R.; Rocha, R.; Rudolph, A.E.; Blomme, E.A.; Polly, M.L.; McMahon, E.G. Kidney Int., 2003, 63,1791.
55. Pfeffer, M.A.; Braunwald, E.; Moye, L.A.; Basta, L; Brown, E.J Jr.; Cuddy, T.E.; Davis, B.R.; Geltman, E.M.; Goldman, S.; Flaker, G.C.; Klein, M.; Lamas, G.A.; Packer, M.; Rouleau, J.; Rouleau, J.L.; Rutherford, J.; Wertheimer, J.H.; Hawkins, C.M. N. Engl. J Med., 1992,327,669.
56. The SOLVD Investigattors. N. Engl. J Med., 1992, 32 7, 685.
57. Fox, K.M. Lancet, 2003,362,782.
58. Yusuf, S.; Sleight, P.; Pogue, J.; Bosch, J.; Davies, R.; Dagenais, G. N. Engl. J Med., 2000, 342,145.
59. Arnold, JM.; Yusuf, S.; Young, J.; Mathew, J.; Johnstone, D.; Avezurn, A.; Loon, E.; Pogue, J.; Bosch, J.; HOPE Investigators. Circulation, 2003, 107,1284.
60. Pfeffer, M.A.; Swedberg, K,; Granger, C.B.; Held, P.; McMurray, J.J.; Michelson, E.L.; Olofsson, B.; Ostergren, J.; Yusuf, S.; Pocock, S.; CHARM Investigators and Committees. Lancet, 2003, 362,759.
61. McMurray, J.J.; Ostergren, J.; Swedberg, K.; Granger, C.B.; Held, P.; Michelson, E.L.; Olofsson, B,; Yusuf, S.; Pfeffer, M.A.; CHARM Investigators and Committees. Lancet, 2003, 3 62, 767.
62. Granger, C.B.; McMurray, J.J.; Yusuf, S.; Held, P.; Michelson, E.L.; Olofsson, B.; Ostergren, J.; Pfeffer, M.A.; Swedberg, K.; CHARM Investigators and Committees. Lancet, 2003,362,772.
63. Yusuf, S., Pfeffer, M.A.; Swedberg, K.; Granger, C.B.; Held, P.; McMurray, J.J.; Michelson, E.L.; Olofsson, B.; Ostergren, J.; CHARM Investigators and Committees. Lancet, 2003, 362, 777.
64. Young, J.B.; Dunlap, M.E.; Pfeffer, M.A.; Probstficld, J.L.; Cohen-Solal, A.; Dietz, R.; Granger, C.B.; Hradec, J.; Koch, J.; McKelvie, R.S.; McMurray, J.J.; Michelson, E.L.; Olofsson, B.; Ostergren, J.; Held, P.; Solomon, S.D.; Yusuf, S.; Swedberg, K.; Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) Investigators and Committees. Circulation, 2004, 110, 2618.
65. Ho, K.K.; Pinsky, J.L.; Kannel, W.B.; Levy, D. J Am. Coll. Cardiol., 1993, 22, 6A.
66. Zhou, X.; Frohlich, E.D. Curr. Opin. Cardiol., 2005, 20, 290.
67. Jafar, T.H.; Schmid, C.H.; Landa, M.; Giatras., I.; Toto, R.; Remuzzi, G.; Maschio, G.; Brenner, B.M.; Kamper, A.; Zucchelfi, P.; Becker, G.; Himmelinann, A.; Bannister, K.; Landais, P.; Shahin- far, S.; de Jong, P.E.; de Zeeuw, D.; Lau, J.; Levey, A.S. Ann. In-tern. Med., 2001, 135, 73.
68. Wright, J.T. Jr.; Bakris, G.; Greene, T.; Agodoa, L.Y.; Appel, L.J.; Charleston, J.;Cheek, D.; Douglas-Baltimore, J.G.; Gassman, J.; Glassock, R.; Hebert, L.;Jamerson, K.; Lewis, J.; Phillips, RA.; Toto, KD.; Middleton, J.P.; Rostand, S.G.;African American Study of Kidney Disease and Hypertension Study Group.JAMA, 2002,288,2421.